Currently, there are 81.19M common shares owned by the public and among those 70.36M shares have been available to trade.
The company’s stock has a 5-day price change of 0.58% and 95.22% over the past three months. ACCD shares are trading 103.22% year to date (YTD), with the 12-month market performance down to -34.56% lower. It has a 12-month low price of $3.08 and touched a high of $11.16 over the same period. ACCD has an average intraday trading volume of 2.00 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.72%, 22.99%, and 45.53% respectively.
Institutional ownership of Accolade Inc (NASDAQ: ACCD) shares accounts for 74.08% of the company’s 81.19M shares outstanding.
It has a market capitalization of $569.85M and a beta (3y monthly) value of 2.19. The earnings-per-share (ttm) stands at -$2.25. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.41% over the week and 0.53% over the month.
Analysts forecast that Accolade Inc (ACCD) will achieve an EPS of 0.21 for the current quarter, -0.14 for the next quarter and -0.14 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.18 while analysts give the company a high EPS estimate of 0.18. Comparatively, EPS for the current quarter was 0.1 a year ago. Earnings per share for the fiscal year are expected to decrease by -3.21%, and 38.38% over the next financial year. EPS should grow at an annualized rate of 22.82% over the next five years, compared to -2.85% over the past 5-year period.
Looking at the support for the ACCD, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on June 28, 2024, with the firm’s price target at $13-$8. Leerink Partners coverage for the Accolade Inc (ACCD) stock in a research note released on February 26, 2024 offered a Outperform rating with a price target of $16. DA Davidson was of a view on January 17, 2024 that the stock is Neutral, while Barclays gave the stock Equal Weight rating on January 03, 2024, issuing a price target of $13. BofA Securities on their part issued Buy rating on May 24, 2023.
